Company Filing History:
Years Active: 2012
Title: Masamichi Yuda: Innovator in Pharmaceutical Cocrystals
Introduction
Masamichi Yuda is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cocrystals that enhance drug stability and efficacy. His innovative work has implications for the preparation of pharmaceuticals, making them more effective and reliable.
Latest Patents
One of Yuda's key patents is titled "Cocrystal of C-glycoside derivative and L-proline." This patent describes a cocrystal of (1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)-4-fluorophenyl]-D-glucitol and L-proline. The cocrystal is derived from a known compound A, which exhibits constant quality, superior storage stability, and no moisture absorptivity. This makes it particularly suitable as a crystal of a drug substance used for preparing pharmaceuticals.
Career Highlights
Throughout his career, Masamichi Yuda has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Astellas Pharma GmbH and Kotobuki Pharmaceutical Co. Ltd. His work in these organizations has allowed him to contribute to advancements in drug formulation and stability.
Collaborations
Yuda has collaborated with several professionals in his field, including Masakazu Imamura and Keita Nakanishi. These collaborations have further enriched his research and development efforts, leading to innovative solutions in pharmaceutical sciences.
Conclusion
Masamichi Yuda's contributions to the field of pharmaceuticals, particularly through his patent on cocrystals, highlight his role as an innovator. His work not only enhances the stability of drug formulations but also paves the way for future advancements in the industry.